Contact
Albert Bourla
www.linkedin.com/in/albert-bourla Chairman and Chief Executive Officer, Pfizer
(LinkedIn) New York, New York, United States
Top Skills Summary
Cross-functional Team Leadership
Albert Bourla leads Pfizer in its purpose, Breakthroughs that change
Pharmaceuticals
patients’ lives, with a focus on driving the scientific and commercial
Vaccines
innovation needed to have a transformational impact on human
health. When he became CEO in 2019, Albert accelerated Pfizer’s
transformation to become a more science-driven, innovative
company and fostered a culture in which people and science could
thrive.
During his more than 25 years at Pfizer, Albert has built a diverse
and successful career, holding senior positions across a range of
markets and disciplines, which has informed his understanding of the
needs of patients and deepened his commitment to helping ensure
equitable access to medicines and vaccines.
Albert is a Doctor of Veterinary Medicine and holds a Ph.D. from the
Veterinary School of Aristotle University. In 2022, he was named
the Genesis Prize Laureate in recognition of his leadership during
the pandemic. In 2021, he was named CEO of the Year by CNN
Business, included in Insider Magazine’s Most Transformative
CEOs list and inducted into the Crain’s New York Business Hall of
Fame. Albert is on the executive committee of The Partnership for
New York City, a vice president of the International Federation of
Pharmaceutical Manufacturers & Associations, a director on multiple
boards and a Trustee of the United States Council for International
Business. He is also a member of the Council on Foreign Relations,
the Business Roundtable, the Business Council and the New York
City Mayor’s Corporate Council.
Experience
Pfizer
Chief Executive Officer
January 2019 - Present (3 years 11 months)
Greater New York City Area
Page 1 of 3
I am the Chief Executive Officer (CEO) of Pfizer, one of the world's premier
innovative biopharmaceutical companies.
In my previous role, I was Chief Operating Officer overseeing the company's
commercial, strategy, manufacturing and global product development
functions.
Pfizer
12 years 8 months
Group President, Pfizer Innovative Health
February 2016 - December 2017 (1 year 11 months)
New York
Led Pfizer Innovative Health which includes six business groups: Consumer
Healthcare, Inflammation & Immunology, Internal Medicine (neuroscience
and pain, and cardiovascular and metabolic), Oncology, Rare Disease and
Vaccines. Each business group is committed to improving health with our
innovative products from prevention to treatment to wellness – at every stage
of life in communities across the globe.
Group President Vaccines, Oncology & Consumer Healthcare (VOC)
January 2014 - January 2016 (2 years 1 month)
New York, NY
Led Pfizer’s Vaccines, Oncology and Consumer Healthcare businesses, three
high-growth organizations focused on positively impacting the lives of people
around the world with our innovative and life-saving and enhancing medicines,
vaccines and consumer products.
President & General Manager Established products Business Unit
2010 - December 2013 (3 years)
New York City
Led the Established Products Business Unit, with responsibility for the
company’s established products (off-patent portfolio - including legacy brands
and generics)
Area President PAH Europe Africa Asia Pacific
May 2005 - November 2010 (5 years 7 months)
Paris, France
Led Pfizer Animal Health in Europe, Africa, Middle East and Asia Pacific
regions.
Pfizer Animal Health
Page 2 of 3
Vice President Business Development and New Products Marketing
2004 - 2005 (1 year)
Education
Aristoteleion Panepistimion Thessalonikis
Doctor of Philosophy (Ph.D.), Biotechnology of Reproduction · (1991)
Aristotle University of Thessaloniki (AUTH)
DVM · (1979 - 1985)
Page 3 of 3
